RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: systemic scleroderma
Accession: DOID:418
browse the term
Definition: A scleroderma that is characterized by fibrosis (or hardening) of the skin and major organs, as well as vascular alterations, and autoantibodies. (DO)
Synonyms: exact_synonym: progressive scleroderma; progressive systemic sclerosis; scleroderma syndrome; systemic sclerosis
narrow_synonym: anti-centromere-antibody-positive systemic scleroderma; anti-topoisomerase-I-antibody-positive systemic scleroderma
primary_id: MESH:D012595
xref: EFO:0000717 ; EFO:0008536 ; EFO:0008537 ; GARD:9748 ; ICD10CM:M34.0 ; ICD9CM:710.1 ; NCI:C72070
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ace
angiotensin I converting enzyme
ISO
protein:decreased expression:plasma
GAD RGD
PMID:15118671 PMID:17360781
RGD:1331525 , RGD:8548889
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Acta2
actin alpha 2, smooth muscle, aorta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24706986
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
protein:decreased expression:plasma (human)
RGD
PMID:12935979
RGD:10449040
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
protein:increased expression:serum
RGD
PMID:18825489 PMID:18825489
RGD:8695973 , RGD:8695973
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agt
angiotensinogen
ISO
protein:decreased expression:plasma
RGD
PMID:17360781
RGD:8548889
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Anxa5
annexin A5
severity
ISO
RGD
PMID:21124692
RGD:7242029
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Arpc2
actin related protein 2/3 complex, subunit 2
ISO
protein:increased expression:saliva (human)
RGD
PMID:17722226
RGD:11049167
NCBI chr 1:74,275,656...74,307,368
Ensembl chr 1:74,275,243...74,307,368
G
Bank1
B cell scaffold protein with ankyrin repeats 1
susceptibility
ISO
DNA:SNPs: :rs10516487,rs17266594(human)
RGD
PMID:19815934
RGD:9684975
NCBI chr 3:135,759,124...136,031,902
Ensembl chr 3:135,759,124...136,031,827
G
Bdnf
brain derived neurotrophic factor
ISO
protein:decreased expression:serum:
RGD
PMID:21085492
RGD:5144060
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
C3
complement component 3
ISO
protein:increased expression:plasma
RGD
PMID:2803327
RGD:7421518
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cav1
caveolin 1, caveolae protein
susceptibility
ISO
DNA:SNPs:enhancer, intron: (rs7795356, rs926198, rs959173) (human) protein:decreased expression:lung, skin
RGD
PMID:22402147 PMID:18759267
RGD:8661768 , RGD:8661773
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Ccl2
C-C motif chemokine ligand 2
severity
ISO
protein:increased expression:respiratory system fluid/secretion protein:increased expression:serum
RGD
PMID:19615053 PMID:21285114 PMID:21049277
RGD:4891453 , RGD:5683876 , RGD:5135284
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl20
C-C motif chemokine ligand 20
ISO
mRNA:increased expression:skin
RGD
PMID:21742595
RGD:7483587
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
Ccl3
C-C motif chemokine ligand 3
ISO
protein:increased expression:serum
RGD
PMID:21285114
RGD:5683876
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccl4
C-C motif chemokine ligand 4
ISO
protein:increased expression:serum
RGD
PMID:21285114
RGD:5683876
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccn1
cellular communication network factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27482699
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Ccn2
cellular communication network factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24706986
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Ccr2
C-C motif chemokine receptor 2
IMP
RGD
PMID:23142052
RGD:9479741
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr6
C-C motif chemokine receptor 6
ISO
mRNA:increased expression:skin
RGD
PMID:21742595
RGD:7483587
NCBI chr17:8,454,875...8,477,353
Ensembl chr17:8,454,875...8,475,973
G
Cd247
CD247 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20383147
NCBI chr 1:165,607,514...165,698,722
Ensembl chr 1:165,616,250...165,704,846
G
Cd86
CD86 antigen
ISO
DNA:snp:5' utr:g.-3479T>G (human)
RGD
PMID:16790753
RGD:4892554
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cfb
complement factor B
ISO
protein:increased expression:plasma
RGD
PMID:2803327
RGD:7421518
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:16195162
RGD:4892666
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Clu
clusterin
ISO
protein:increased expression:serum
RGD
PMID:22350181
RGD:8898558
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27228633
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Cnr2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27228633
NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
G
Col1a1
collagen, type I, alpha 1
ISO
RGD
PMID:1697606
RGD:5688336
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24706986
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Col3a1
collagen, type III, alpha 1
IAGP
OMIM:181750
MouseDO
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Cp
ceruloplasmin
ISO
protein:increased expression:serum
RGD
PMID:32630589
RGD:401827129
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
G
Csf1
colony stimulating factor 1 (macrophage)
ISO
mRNA:increased expression:skin
RGD
PMID:22700848
RGD:7257593
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:serum
RGD
PMID:15608300
RGD:4891898
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO IMP
protein:increased expression:lung, skin DNA:polymorphisms: :p.V249I, p.T280M (human)
RGD
PMID:15608300 PMID:23142052 PMID:16584113
RGD:4891898 , RGD:9479741 , RGD:4891896
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:serum
RGD
PMID:21303517 PMID:21049277
RGD:5135279 , RGD:5135284
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl16
C-X-C motif chemokine ligand 16
ISO
protein:increased expression:serum, skin, endothelial cell
RGD
PMID:21303517
RGD:5135279
NCBI chr11:70,345,215...70,350,810
Ensembl chr11:70,344,809...70,350,810
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:serum
RGD
PMID:21303517 PMID:21049277
RGD:5135279 , RGD:5135284
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
protein:decreased expression:skin, endothelial cell
RGD
PMID:21303517
RGD:5135279
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
G
Cxcr6
C-X-C motif chemokine receptor 6
ISO
protein:increased expression:skin, endothelial cell
RGD
PMID:21303517
RGD:5135279
NCBI chr 9:123,635,542...123,640,819
Ensembl chr 9:123,635,540...123,640,825
G
Edn1
endothelin 1
ISO
protein:increased secretion:plasma (human)
RGD
PMID:7653485
RGD:4145072
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Eln
elastin
ISO
RGD
PMID:22563211
RGD:9585742
NCBI chr 5:134,731,449...134,776,300
Ensembl chr 5:134,731,447...134,776,177
G
Esr1
estrogen receptor 1 (alpha)
susceptibility
ISO
DNA:SNP:intron:
RGD
PMID:19032828
RGD:8553058
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
no_association
ISO
DNA:SNP:exon:
RGD
PMID:19032828
RGD:8553058
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
F11r
F11 receptor
ISO
RGD
PMID:19153103
RGD:7488918
NCBI chr 1:171,265,129...171,292,161
Ensembl chr 1:171,265,103...171,292,171
G
F2
coagulation factor II
ISO
protein:increased expression:plasma:
RGD
PMID:9374919
RGD:11565087
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
Fbn1
fibrillin 1
susceptibility
IMP ISO IAGP
DNA:insertion:5' utr OMIM:181750
MouseDO RGD
PMID:11123012 PMID:12384286 PMID:10395706
RGD:7387265 , RGD:12904889 , RGD:12910471
NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
G
Fli1
Friend leukemia integration 1
IAGP
OMIM:181750
MouseDO
NCBI chr 9:32,333,500...32,454,292
Ensembl chr 9:32,333,500...32,454,157
G
Flt4
FMS-like tyrosine kinase 4
ISO
protein:increased expression:skin:
RGD
PMID:21865112
RGD:8552335
NCBI chr11:49,500,506...49,543,566
Ensembl chr11:49,500,090...49,543,566
G
Fosl2
fos-like antigen 2
IAGP
OMIM:181750
MouseDO
NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186
G
Fstl1
follistatin-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27482699
NCBI chr16:37,597,417...37,656,878
Ensembl chr16:37,597,235...37,656,876
G
Gpx3
glutathione peroxidase 3
ISO
protein:decreased expression:serum
RGD
PMID:32630589
RGD:401827129
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gstm1
glutathione S-transferase, mu 1
susceptibility
ISO
DNA:missense mutation:cds:p.K173N (human)
RGD
PMID:15135176
RGD:12798510
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphism::HLA-DQA1*0501;
RGD
PMID:11014350
RGD:8547725
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20383147
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
Hdac5
histone deacetylase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27482699
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
G
Hgf
hepatocyte growth factor
treatment severity
ISO
mRNA:increased expression:skin: protein:increased expression:serum:
RGD
PMID:17049072 PMID:22286923 PMID:24387171
RGD:8548624 , RGD:8548651 , RGD:8548659
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Hmgb1
high mobility group box 1
IEP
protein:increased expression:serum
RGD
PMID:18825489
RGD:8695973
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hnrnpl
heterogeneous nuclear ribonucleoprotein L
ISO
RGD
PMID:21569507
RGD:9999440
NCBI chr 7:28,507,971...28,521,693
Ensembl chr 7:28,507,966...28,521,691
G
Icam1
intercellular adhesion molecule 1
disease_progression
ISO
protein:increased expression:blood
RGD
PMID:18759276 PMID:1371389 PMID:8099861
RGD:8158120 , RGD:8547576 , RGD:8547587
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:1418004
RGD:8157622
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
protein:increased expression:serum:
RGD
PMID:19004037
RGD:12743606
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Il13
interleukin 13
no_association
IEP ISO
mRNA, protein:increased expression:skin protein:increased expression:serum DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human)
RGD
PMID:15564778 PMID:9034992 PMID:22045834
RGD:5684370 , RGD:5684371 , RGD:8549502
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il13ra1
interleukin 13 receptor, alpha 1
no_association
ISO
DNA:SNP:intron:43163G>A (rs6646259) (human)
RGD
PMID:22045834
RGD:8549502
NCBI chr X:35,375,761...35,434,915
Ensembl chr X:35,375,763...35,434,912
G
Il17a
interleukin 17A
IMP ISO
protein:increased expression:epidermis, endodermis, mast cell (human)
RGD
PMID:22833167 PMID:23335253
RGD:8696037 , RGD:8696038
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il1b
interleukin 1 beta
susceptibility
ISO
DNA:polymorphisms:promoter:-31T>C,-511C>T (human)
RGD
PMID:17444587
RGD:4142872
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1r1
interleukin 1 receptor, type I
ISO
RGD
PMID:1375465
RGD:8662902
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
G
Il2
interleukin 2
ISO
protein:increased expression:serum:
RGD
PMID:2213757
RGD:8663482
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs11209026, rs11465804 (human) DNA:SNPs: :rs11209032,rs1495965(human)
RGD
PMID:19918037 PMID:18713787
RGD:5096624 , RGD:8549603
NCBI chr 6:67,399,906...67,468,838
Ensembl chr 6:67,399,916...67,468,839
G
Il27
interleukin 27
ISO
protein:increased expression:serum
RGD
PMID:20705635
RGD:5128477
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il27ra
interleukin 27 receptor, alpha
ISO
mRNA:increased expression:skin
RGD
PMID:20705635
RGD:5128477
NCBI chr 8:84,756,915...84,769,250
Ensembl chr 8:84,756,923...84,769,218
G
Il4
interleukin 4
ISO
protein:increased expression:serum mRNA, protein:increased expression, splice variant:blood, mononuclear cell, plasma
RGD
PMID:9034992 PMID:10473513
RGD:5684371 , RGD:7829819
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6
interleukin 6
treatment
ISO
RGD
PMID:23406616
RGD:12792238
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irf5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20383147
NCBI chr 6:29,526,129...29,541,874
Ensembl chr 6:29,526,624...29,541,870
G
Jam3
junction adhesion molecule 3
ISO
protein:increased expression:skin protein:decreased expression:skin, endothelial cell
RGD
PMID:23001478 PMID:19439502
RGD:7488920 , RGD:7488937
NCBI chr 9:27,008,680...27,066,739
Ensembl chr 9:27,008,680...27,066,717
G
Kdr
kinase insert domain protein receptor
ISO
protein:decreased expression:bone marrow: protein:increased expression:skin:
RGD
PMID:22271757 PMID:21865112
RGD:8551843 , RGD:8552335
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Lta
lymphotoxin A
susceptibility
ISO
DNA:SNP:intron:252A>G (human)
RGD
PMID:10600011
RGD:8548796
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
G
Mmp1a
matrix metallopeptidase 1a (interstitial collagenase)
severity
ISO
mRNA:decreased expression:skin protein:increased expression:serum
RGD
PMID:22286923 PMID:12051403
RGD:8548651 , RGD:8693663
NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
severity
ISO
protein:increased expression:serum mRNA:decreased expression:skin
RGD
PMID:12051403 PMID:22286923
RGD:8548651 RGD:8693663
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp3
matrix metallopeptidase 3
severity
ISO
protein:increased expression:serum
RGD
PMID:12051403 PMID:15498049
RGD:8693663 , RGD:8693674
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:15642145
RGD:1580577
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Muc1
mucin 1, transmembrane
ISO
protein:increased expression:serum
RGD
PMID:19286849
RGD:4143496
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:10599336
RGD:5147680
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Nectin2
nectin cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27482699
NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum
RGD
PMID:21085492
RGD:5144060
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Notch4
notch 4
ISO
DNA: SNPs: non-coding :multiple
RGD
PMID:21779181
RGD:6480691
NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
G
Pecam1
platelet/endothelial cell adhesion molecule 1
IEP
protein:decreased expression:superficial vasculature (human)
RGD
PMID:20228226
RGD:11541095
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pf4
platelet factor 4
severity
ISO
RGD
PMID:34556381
RGD:329901818
NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21979415
RGD:5508306
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
no_association
ISO
DNA: snp: cds: rs2476601 DNA:missense mutation:cds:p.R620W (rs2476601) (human)
RGD
PMID:21131644 PMID:16464986
RGD:6484551 , RGD:7829741
NCBI chr 3:103,763,891...103,819,568
Ensembl chr 3:103,767,111...103,819,563
G
Rbp4
retinol binding protein 4, plasma
disease_progression
ISO
associated with Raynaud disease and interstitial lung disease; protein:decreased expression:blood serum (human)
RGD
PMID:22211766
RGD:329845579
NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
G
Rhob
ras homolog family member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21750679
NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009
G
S1pr5
sphingosine-1-phosphate receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29033951
NCBI chr 9:21,154,213...21,159,739
Ensembl chr 9:21,154,208...21,159,739
G
Selenop
selenoprotein P
ISO
protein:decreased expression:serum
RGD
PMID:32630589
RGD:401827129
NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
ISO
protein:increased expression:dermis,microvessel:
RGD
PMID:26414805
RGD:11343779
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf2
serine (or cysteine) peptidase inhibitor, clade F, member 2
ISO
protein:increased expression:plasma
RGD
PMID:12595617
RGD:1625530
NCBI chr11:75,322,562...75,330,327
Ensembl chr11:75,322,558...75,330,417
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25707573
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Sirt7
sirtuin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25707573
NCBI chr11:120,509,197...120,515,840
Ensembl chr11:120,509,198...120,516,066
G
Slc11a1
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
ISO
DNA:repeat, polymorphism:promoter, intron: (human)
RGD
PMID:17876529
RGD:5684940
NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221
G
Stat4
signal transducer and activator of transcription 4
susceptibility
ISO
DNA:SNP:intron: (rs7574865) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs11889341) (human)
CTD RGD
PMID:20383147 PMID:19644887 PMID:19950257
RGD:8661700 , RGD:8661711
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Tgfbr1
transforming growth factor, beta receptor I
IAGP
OMIM:181750
MouseDO
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Tnip1
TNFAIP3 interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21750679
NCBI chr11:54,801,613...54,853,766
Ensembl chr11:54,801,611...54,853,743
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:skin mRNA,protein:increased expression:skin: protein:increased expression:serum: protein:increased expression:bone marrow:
RGD
PMID:16426919 PMID:21636803 PMID:24387171 PMID:22271757
RGD:5684416 , RGD:7421579 , RGD:8548659 , RGD:8551843
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vwf
Von Willebrand factor
severity
ISO
RGD
PMID:22596213
RGD:7205639
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Cenpc1
centromere protein C1
ISO
associated with Anticentromere antibody positivity
RGD
PMID:25220385
RGD:27372886
NCBI chr 5:86,159,877...86,214,325
Ensembl chr 5:86,159,883...86,213,442
G
Fbn1
fibrillin 1
ISO
RGD
PMID:10395706
RGD:12910471
NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
G
Adipoq
adiponectin, C1Q and collagen domain containing
severity
ISO
protein:decreased expression:serum
RGD
PMID:21615510
RGD:8694418
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Agt
angiotensinogen
ISO
protein:increased expression:serum
RGD
PMID:14730619
RGD:8548886
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Bank1
B cell scaffold protein with ankyrin repeats 1
susceptibility
ISO
DNA:SNPs: :rs10516487,rs17266594,rs3733197(human)
RGD
PMID:19815934
RGD:9684975
NCBI chr 3:135,759,124...136,031,902
Ensembl chr 3:135,759,124...136,031,827
G
Cav1
caveolin 1, caveolae protein
susceptibility no_association
ISO
DNA:SNPs:intron, 3' utr: (rs729949, rs3815412, rs9920) (human) DNA:SNPs:enhancer, intron:multiple
RGD
PMID:22402147 PMID:22402147
RGD:8661768 , RGD:8661768
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Cxcl5
C-X-C motif chemokine ligand 5
ISO
RGD
PMID:18432520
RGD:5135258
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphism::HLA-DQA1*0501;
RGD
PMID:11014350
RGD:8547725
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
Il10
interleukin 10
ISO
protein:increased expression:serum
RGD
PMID:9034992
RGD:5684371
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
ISO
DNA:SNPs:5' utr, enhancer: (rs1800925, rs2243204) (human)
RGD
PMID:16832637
RGD:5684369
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il6
interleukin 6
treatment
ISO
RGD
PMID:20338043
RGD:12792275
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak1
interleukin-1 receptor-associated kinase 1
susceptibility
ISO
DNA:missense mutation:cds:p.F196S (rs1059702) (human)
RGD
PMID:21898345
RGD:7495782
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
G
Kdr
kinase insert domain protein receptor
ISO
protein:increased expression:serum:
RGD
PMID:19886888
RGD:8551850
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Stat4
signal transducer and activator of transcription 4
susceptibility no_association
ISO
DNA:SNP:introns: (rs7574865, rs10168266) (human) DNA:SNP:intron: (rs7574865) (human) DNA:SNP:intron: (rs3821236) (human)
RGD
PMID:23755762 PMID:19286670 PMID:23755762
RGD:8661701 , RGD:8661714 , RGD:8661701
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Tap1
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
susceptibility
ISO
RGD
PMID:16112028
RGD:1578361
NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
susceptibility
ISO
RGD
PMID:16112028
RGD:1578361
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
G
Tgfbr1
transforming growth factor, beta receptor I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27228633
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Tlr2
toll-like receptor 2
disease_progression
ISO
DNA:polymorphism:cds:p.P631H(rs5743704)(human)
RGD
PMID:21905008
RGD:8553044
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Wrn
Werner syndrome RecQ like helicase
ISO
RGD
PMID:16906373
RGD:10042980
NCBI chr 8:33,724,400...33,875,591
Ensembl chr 8:33,724,412...33,875,555
G
Cav1
caveolin 1, caveolae protein
susceptibility no_association
ISO
DNA:SNPs:enhancer, intron:multiple DNA:SNPs:3' utr, intron: (rs9920, rs729949, rs3815412) (human)
RGD
PMID:22402147 PMID:22402147
RGD:8661768 , RGD:8661768
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Ccl2
C-C motif chemokine ligand 2
IMP IEP
mRNA,protein:increased expression:skin:
RGD
PMID:12925209 PMID:12925209
RGD:8661733 , RGD:8661733
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccr2
C-C motif chemokine receptor 2
IEP
mRNA,protein:increased expression:skin:
RGD
PMID:12925209
RGD:8661733
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Fas
Fas cell surface death receptor
IMP
RGD
PMID:17102953
RGD:12903974
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
IMP
RGD
PMID:17102953
RGD:12903974
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Il2
interleukin 2
susceptibility
ISO
DNA:polymorphism::-384T>G(human)
RGD
PMID:17444587
RGD:4142872
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Jak2
Janus kinase 2
ISO
RGD
PMID:20808962
RGD:4892610
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Kdr
kinase insert domain protein receptor
ISO
protein:increased expression:serum:
RGD
PMID:19886888
RGD:8551850
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Pgf
placental growth factor
ISO
protein:increased expression:plasma
RGD
PMID:22461185
RGD:6483571
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
IEP
mRNA,protein:increased expression:skin:
RGD
PMID:15730388
RGD:13208597
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Stat4
signal transducer and activator of transcription 4
no_association susceptibility
ISO
DNA:SNPs:introns: (rs10168266, rs3821236) (human) DNA:SNP:intron: (rs7574865) (human)
RGD
PMID:23755762 PMID:23755762 PMID:19286670
RGD:8661701 , RGD:8661701 , RGD:8661714
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
susceptibility
ISO
RGD
PMID:16112028
RGD:1578361
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
G
Lbr
lamin B receptor
ISO
ClinVar Annotator: match by term: PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA | ClinVar Annotator: match by term: Reynolds syndrome
OMIM ClinVar
PMID:18382993 PMID:20522425 PMID:23824842 PMID:24033266 PMID:25348816 PMID:25741868 PMID:26467025 PMID:28492532 PMID:30448303 PMID:32827848 PMID:34567078 PMID:36307859 More...
NCBI chr 1:181,642,880...181,669,933
Ensembl chr 1:181,642,900...181,670,611
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all